InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Robertson Jenny. Director active across 1 company, notably Lexeo Therapeutics, Inc.. In total, 5 disclosures have been published. Split: 0 buy · 2 sells. Total volume traded: €10k. Activity tracked since 5 January 2024. The latest transaction was disclosed on 16 May 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
5 of 5 declarations